Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Subcutaneous Rehydration Compared to Intravenous Rehydration (PEDs-II)

This study has been completed.
Sponsor:
Collaborator:
Baxter Healthcare Corporation
Information provided by:
Halozyme Therapeutics
ClinicalTrials.gov Identifier:
NCT00773175
First received: October 15, 2008
Last updated: December 2, 2011
Last verified: December 2011